Evidence map›Paper›PMID 33354048›Full record

ReviewIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine2020

Basic Critical Care for Management of COVID-19 Patients: Position Paper of Indian Society of Critical Care Medicine, Part-I.

Deven Juneja, Raymond D Savio, Shrikanth Srinivasan, Rahul A Pandit, Suresh Ramasubban, Pavan K Reddy, Manoj Singh, Palepu Bn Gopal, Dhruva Chaudhry, Deepak Govil and 2 more

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Prevalence of Frailty in ICU and its Impact on Patients' Outcomes.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2023
    Article
  2. Article
  3. Procalcitonin (in COVID-19): The Incessant Quest.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Deven JunejaInstitute of Critical Care Medicine, Max Super Speciality Hospital, New Delhi, India.
Raymond D SavioDepartment of Critical Care Medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.
Shrikanth SrinivasanDepartment of Critical Care Medicine, Manipal Hospitals, New Delhi, India.
Rahul A PanditDepartment of Intensive Care, Fortis Hospital, Mulund, Maharashtra, India.
Suresh RamasubbanDepartment of Critical Care, Apollo Gleneagles Hospitals, Kolkata, West Bengal, India.
Pavan K ReddyDepartment of Critical Care, CARE-Banjara, Hyderabad, Telangana, India.
Manoj SinghDepartment of Critical Care, Apollo Hospitals International Limited, Ahmedabad, Gujarat, India.
Palepu Bn GopalDepartment of Critical Care, Continental Hospitals, Hyderabad, Telangana, India.
Dhruva ChaudhryDepartment of Pulmonary and Critical Care, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.
Deepak GovilInstitute of Critical Care and Anesthesia, Medanta: The Medicity, Gurugram, Haryana, India.
Shubhal DixitDepartment of Critical Care Medicine, Sanjeevan and MJM Hospital, Pune, Maharashtra, India.
Srinivas SamavedamDepartment of Critical Care, Virinchi Hospital, Hyderabad, Telangana, India.
Apollo Gleneagles Hospitals · INApollo Hospitals · INApollo Hospitals · INMax Super Speciality Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With more than 23 million infections and more than 814,000 deaths worldwide, the coronavirus disease-2019 (COVID-19) pandemic is still far from over. Several classes of drugs including antivirals, antiretrovirals, anti-inflammatory, immunomodulatory, and antibiotics have been tried with varying levels of success. Still, there is lack of any specific therapy to deal with this infection. Although less than 30% of these patients require intensive care unit admission, morbidity and mortality in this subgroup of patients remain high. Hence, it becomes imperative to have general principles to guide intensivists managing these patients. However, as the literature emerges, these recommendations may change and hence, frequent updates may be required.

Indexed as

AntiviralsCorticosteroidsCOVID-19Critical careIntensive careSARS-CoV-2

Identifiers

PMID33354048
PMCPMC7724932
OpenAlexW4246217242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.